CEL — Celadon Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Celadon Pharmaceuticals, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.

	2019 August 31st	2020 August 31st	R2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	5.65	5.49	3.82	5.06	1.26
Net Total Accounts Receivable
Net Total Receivables	0.016	0.01	0.104	1.06	0.841
Total Inventory
Prepaid Expenses
Total Current Assets	5.66	5.5	4.09	6.33	2.5
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	—	—	3.31	6.28	6.17
Net Goodwill
Net Intangible Assets
Long Term Investments
Total Assets	5.66	5.5	8.76	13.3	9.22
Payable / Accrued
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	0.021	0.03	8.58	1.2	0.955
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	0.033	0.042	12.9	5.58	6.06
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	5.63	5.46	-4.14	7.67	3.16
Total Liabilities & Shareholders' Equity	5.66	5.5	8.76	13.3	9.22
Total Common Shares Outstanding